Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Bas B. Koolen"'
Autor:
Mette S. van Ramshorst, Suzana C. Teixeira, Bas B. Koolen, Kenneth E. Pengel, Kenneth G. Gilhuijs, Jelle Wesseling, Sjoerd Rodenhuis, Renato A. Valdés Olmos, Emiel J. Rutgers, Wouter V. Vogel, Gabe S. Sonke, Marie-Jeanne T. Vrancken Peeters
Publikováno v:
Cancer Imaging, Vol 17, Iss 1, Pp 1-8 (2017)
Abstract Background 18F-FDG PET/CT can monitor metabolic activity in early breast cancer during neoadjuvant systemic therapy (NST), but it is unknown if the metabolic breast and axillary response differ. We evaluated the correlation between metabolic
Externí odkaz:
https://doaj.org/article/829353bcba674cc7be37d6a13918883f
Autor:
Marcel P. M. Stokkel, Vincent van der Noort, Suzana C Teixeira, Bas B. Koolen, M.T.F.D. Vrancken Peeters, Sjoerd Rodenhuis, E.J.T. Rutgers, R.A. Valdés Olmos, P. Elkhuizen
Publikováno v:
European journal of surgical oncology, 43(4), 625-635. W.B. Saunders Ltd
Introduction: F-18-FDG PET/CT has high positive predictive value for the detection of avid lymph node metastases in breast cancer patients. We analysed the effect of upstaging lymph nodes by PET/CT on short-term outcome in stage II/III breast cancer
Autor:
Marie-Jeanne T. F. D. Vrancken Peeters, Bas B. Koolen, Suzana C Teixeira, Renato A. Valdés Olmos, Emiel J T Rutgers, Marcel P. M. Stokkel
Publikováno v:
Breast Cancer Management. 4:165-174
SUMMARY Modalities that are conventionally used for regional and distant metastases staging, in clinical stage II/III breast cancer patients (ultrasonography, computed tomography [CT], MRI and bone scan), may underestimate the spread of the disease.
Autor:
Suzana C Teixeira, Bas B. Koolen, Jelle Wesseling, Marie-Jeanne T. F. D. Vrancken Peeters, Emiel J. Th. Rutgers, Gabe S. Sonke, Sjoerd Rodenhuis, Renato A. Valdés Olmos, Mette S. van Ramshorst, Kenneth E. Pengel, Kenneth G. A. Gilhuijs, Wouter V. Vogel
Publikováno v:
Cancer Imaging, Vol 17, Iss 1, Pp 1-8 (2017)
Cancer imaging, 17(1). e-med
Cancer Imaging, 17(1). e-med
Cancer Imaging
Cancer imaging, 17(1). e-med
Cancer Imaging, 17(1). e-med
Cancer Imaging
Background 18F-FDG PET/CT can monitor metabolic activity in early breast cancer during neoadjuvant systemic therapy (NST), but it is unknown if the metabolic breast and axillary response differ. We evaluated the correlation between metabolic breast a
Autor:
Kenneth E. Pengel, Sjoerd Rodenhuis, Jelle Wesseling, Kenneth G. A. Gilhuijs, Wouter V. Vogel, Claudette E. Loo, Emiel J. Th. Rutgers, Marie Jeanne T.F.D. Vrancken Peeters, Bas B. Koolen, Esther H. Lips, Renato A. Valdés Olmos
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 41:1515-1524
Purpose To explore the potential complementary value of PET/CT and dynamic contrast-enhanced MRI in predicting pathological response to neoadjuvant chemotherapy (NAC) of breast cancer and the dependency on breast cancer subtype.
Autor:
Peter M. Rosseel, Paul G.H. Mulder, Joost A.M. Labout, Tom A. Rijpstra, Mohamed Bentala, Bas B. Koolen, Nardo J. M. van der Meer, Bastiaan M. Gerritse
Publikováno v:
Interactive CardioVascular and Thoracic Surgery. 17:608-614
Prediction of atrial fibrillation (AF) after coronary artery bypass grafting (CABG) may lead to preventive or early treatment and improved outcome. We investigated the association of serial perioperative cardiac troponin T (cTNT) measurements with po
Autor:
Femke van der Leij, Marie-Jeanne T. F. D. Vrancken Peeters, Emiel J. Th. Rutgers, Paula H.M. Elkhuizen, Bas B. Koolen, Renato A. Valdés Olmos, Wouter V. Vogel
Publikováno v:
Acta Oncologica. 53:50-57
Background. The aim of this study was to assess the accuracy of 18F-FDG PET/CT in T1 breast cancer regarding visualization of the primary tumor and the detection of locoregional and distant metastases. Methods. Sixty-two women with invasive T1 breast
Autor:
Marie-Jeanne T. F. D. Vrancken Peeters, Sjoerd Rodenhuis, Emiel J. Th. Rutgers, Andrew D. Vincent, Kenneth G. A. Gilhuijs, Bas B. Koolen, Wouter V. Vogel, Jelle Wesseling, Renato A. Valdés Olmos
Publikováno v:
Annals of Surgical Oncology. 20:2227-2235
Background If all initially node-positive patients undergo axillary lymph node dissection (ALND) after neoadjuvant chemotherapy (NAC), overtreatment may occur in patients with complete response. Positron emission tomography–computed tomography (PET
Autor:
Renato A. Valdés Olmos, Marie Jeanne T.F.D. Vrancken Peeters, Paula H.M. Elkhuizen, Wouter V. Vogel, Sjoerd Rodenhuis, Emiel J. Th. Rutgers, Bas B. Koolen
Publikováno v:
Breast cancer research and treatment, 141(2), 249-254. Springer New York
In breast cancer patients treated with neoadjuvant chemotherapy (NAC) the number of tumor-positive nodes can no longer reliably be determined. Furthermore, ultrasound (US) seems suboptimal for the detection of N3-disease. Therefore we assessed the pr
Autor:
M.E.M. van der Noordaa, Bas B. Koolen, M. Donker, Marieke E. Straver, E.J.T. Rutgers, R.A. Valdés Olmos, M.T.F.D. Vrancken Peeters
Publikováno v:
The British journal of surgery. 104(9)
Background The treatment of axillary lymph node metastases after neoadjuvant systemic therapy (NST) remains debatable and axillary lymph node dissection (ALND) is still the standard of care. Marking axillary lymph nodes with radioactive iodine seeds